JVMTX | NQVAX | JVMTX / NQVAX | |
Total Expense Ratio | 1.00 | 1.16 | 86% |
Annual Report Gross Expense Ratio | 1.11 | 1.17 | 95% |
Fund Existence | 12 years | 23 years | - |
Gain YTD | 7.878 | 6.997 | 113% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.6B | 545M | 4,147% |
Annual Yield % from dividends | 0.65 | 1.24 | 52% |
Returns for 1 year | -1.55 | 10.47 | -15% |
Returns for 3 years | 23.85 | 60.78 | 39% |
Returns for 5 years | 56.21 | 126.35 | 44% |
Returns for 10 years | 44.77 | 147.70 | 30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSP | 184.25 | 1.49 | +0.82% |
Invesco S&P 500® Equal Weight ETF | |||
UPAR | 13.81 | 0.11 | +0.81% |
UPAR Ultra Risk Parity ETF | |||
ADVE | 36.15 | 0.22 | +0.62% |
Matthews Asia Dividend Active ETF | |||
BOCT | 45.94 | 0.20 | +0.44% |
Innovator U.S. Equity Buffer ETF™ Oct | |||
NRK | 9.50 | -0.08 | -0.84% |
Nuveen New York AMT-Free Quality Municipal Income Fund |